Percentage of patients with a solid malignant tumor or lymphoma who had a febrile neutropenia (FN) risk assessment completed and documented in the medical record prior to the first cycle of intravenous chemotherapy
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Number of patients who had an FN risk assessment documented in the medical record prior to the first cycle of intravenous chemotherapy.
-
1.15 Denominator
Number of patients 18 years of age or older with a solid malignant tumor or lymphoma receiving the first cycle of intravenous chemotherapy.
-
Exclusions
There are no denominator exclusions.
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Cancer Spring Cycle 2021Initial EndorsementLast UpdatedRemoval Date
-
Steward Organization EmailSteward Organization Copyright
Some proprietary codes are contained in the measure specifications for convenience of the user. Use of these codes may require permission from the code owner or agreement to a license.
ICD-10 codes are copyrighted © World Health Organization (WHO), Fourth Edition, 2010. CPT © 2010 American Medical Association. CPT is a registered trademark of the American Medical Association. All rights reserved.
-
-
-
Risk Adjustment
-